https://www.insurerbrain.com/w/index.php?action=history&feed=atom&title=Definition%3AFunding_roundDefinition:Funding round - Revision history2026-04-30T07:56:21ZRevision history for this page on the wikiMediaWiki 1.43.8https://www.insurerbrain.com/w/index.php?title=Definition:Funding_round&diff=16392&oldid=prevPlumBot: Bot: Creating new article from JSON2026-03-15T06:28:04Z<p>Bot: Creating new article from JSON</p>
<p><b>New page</b></p><div>💰 '''Funding round''' refers to a discrete stage of external capital raising by a company — typically a startup or growth-stage venture — from investors in exchange for equity, convertible instruments, or other securities. In the [[Definition:Insurtech | insurtech]] sector, funding rounds are the primary mechanism through which technology-driven insurance companies, [[Definition:Managing general agent (MGA) | MGAs]], and platform providers finance product development, regulatory licensing, market expansion, and talent acquisition. Rounds are conventionally labeled by stage — pre-seed, seed, Series A, Series B, and beyond — each reflecting the company's maturity, valuation trajectory, and the type of investor typically involved, from angel investors and accelerators at the earliest stages to venture capital firms, [[Definition:Private equity | private equity]] sponsors, and strategic investors from the insurance industry at later stages.<br />
<br />
📈 The mechanics of a funding round involve the company issuing new shares (or convertible notes that later convert into shares) at a negotiated valuation, thereby diluting existing shareholders in exchange for fresh capital. Key terms include the pre-money valuation (the company's agreed value before the investment), the post-money valuation (pre-money plus the capital raised), [[Definition:Liquidation preference | liquidation preferences]], anti-dilution protections, and board governance rights. In insurtech, later-stage rounds frequently attract participation from incumbent [[Definition:Insurance carrier | insurers]] and [[Definition:Reinsurer | reinsurers]] acting as strategic investors — companies like [[Definition:Munich Re | Munich Re]], [[Definition:AXA | AXA]], and various Asian insurers have maintained venture arms or partnership funds specifically to invest in insurance technology companies. These strategic rounds serve a dual purpose: they provide capital to the insurtech while giving the investing insurer early access to innovative technology, distribution channels, or [[Definition:Underwriting | underwriting]] capabilities.<br />
<br />
🔑 Funding rounds are a barometer of investor confidence in the insurtech ecosystem and, more broadly, in the pace of innovation within the insurance industry. Periods of robust fundraising activity — such as the surge in insurtech investment between 2019 and 2021 — signal optimism about technology's potential to transform [[Definition:Distribution channel | distribution]], [[Definition:Claims management | claims handling]], and risk selection, while downturns in funding often correlate with tightened valuations and greater investor scrutiny of unit economics and paths to [[Definition:Profitability | profitability]]. For traditional insurers evaluating potential partners or acquisition targets, understanding an insurtech's funding history — including the identity of its investors, the terms of each round, and the capital deployed relative to revenue — provides critical insight into the company's financial runway, strategic backing, and long-term viability.<br />
<br />
'''Related concepts:'''<br />
{{Div col|colwidth=20em}}<br />
* [[Definition:Insurtech]]<br />
* [[Definition:Venture capital]]<br />
* [[Definition:Private equity in insurance]]<br />
* [[Definition:Valuation]]<br />
* [[Definition:Strategic investment]]<br />
* [[Definition:Initial public offering (IPO)]]<br />
{{Div col end}}</div>PlumBot